To maintain health, the immune system must maintain a delicate balance between eliminating invading pathogens and avoiding immune disorders such as autoimmunity and allergies. The gut microbiota provide essential health benefits to the host, particularly by regulating immune homeostasis. Dysbiosis, an alteration and imbalance of the gut microbiota, is associated with the development of several autoimmune diseases in both mice and humans. In this review, we discuss recent advances in understanding how certain factors, such as age and gender, affect the gut microbiota, which in turn can influence the development of autoimmune diseases. The age factor in microbiota-dependent immune disorders indicates a window of opportunity for future diagnostic and therapeutic approaches. We also discuss unique commensal bacteria with strong immunomodulatory activity. Finally, we provide an overview of the potential molecular mechanisms whereby gut microbiota induce autoimmunity, as well as the evidence that gut microbiota trigger extraintestinal diseases by inducing the migration of gut-derived immune cells. Elucidating the interaction of gut microbiota and the host immune system will help us understand the pathogenesis of immune disorders, and provide us with new foundations to develop novel immuno-or microbe-targeted therapies.
Introduction
Microbes have traditionally been classified according to their relationship with their host: pathogens are harmful and invasive to the host, while commensals are normally harmless. Pathogens, including bacteria and viruses, have long been associated with autoimmune diseases. 1, 2 Recently, expansions of pathogenic commensal bacteria-pathobiontshave been found in patients with autoimmune diseases and in animal autoimmune models. These types of commensals, often not normally pathogenic themselves, can trigger autoimmune symptoms in genetically susceptible hosts. Notably, the recent explosion of findings in the microbiota field has been greatly facilitated by the advancement of modern technology. The 16S ribosomal RNA (rRNA) subunit is an essential component in the ribosomal complex in prokaryotes. 3 Owing to its conservation in evolution, the 16S rRNA gene is the most established marker for bacterial classification and taxonomic assignment. Because the majority of gut microbiota are unculturable, the 16S rRNA sequencing analysis, which is used by most of the studies discussed below, has replaced the traditional culture-based techniques for characterizing microbial communities in any given sample. 4 Here, we review factors affecting the role of microbiota in autoimmunity, as well as the mechanisms whereby microbiota trigger an autoimmune response, with a focus on gut microbiota. This is an urgent subject, as dysbiosis-related diseases have emerged as new epidemics in the industrialized world. [5] [6] [7] It is important to emphasize that despite the focus of this review on the potential detrimental role of microbiota in autoimmunity, a healthy commensal community is beneficial to the host; for example, commensal bacteria can provide crucial nutrients, such as vitamins B and K, as well as control immune homeostasis (extensively discussed in a recent review.
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The role of microbiota and gender in autoimmune development
The gender dimorphism of susceptibility to autoimmune disease is a well-established phenomenon. 9 The seminal discovery by Markle et al. 10 provides a new perspective into the role of sex hormones in autoimmune disease development. Their study demonstrated that male puberty in non-obese diabetic (NOD) mice leads to changes in the gut microbiota that result in enhanced testosterone production, which protects against the development of type 1 diabetes (T1D). 10 Importantly, the protective properties of the male-associated microbiota could be transferred to immature females. The protective effects correspond with an increase in male-like microbiota in recipient females and are dependent on androgen receptor activity. This study suggests a clear interaction between microbiota and sex hormones, raising the possibility that microbial transplantation might serve as a therapy for autoimmune diseases. Another research group also found different microbiota profiles between male and female NOD mice. 11 They further observed that the loss of interferon ␥ (IFN-␥ ) signaling removes the gender bias from T1D, suggesting that IFN-␥ signaling is required in sex-and microbiota-mediated disease protection.
Using a different disease model, Miller et al. demonstrated that the combined factors of gender and microbiota profile might predispose female myelin oligodendrocyte glycoproteinspecific 2D2 TCR transgenic mice with a TNF receptor 2 (TNFR2) deficiency to develop spontaneous autoimmune central nervous system demyelination. 12 Fecal 16S rRNA analysis identified a distinct microbiota profile in male Tnfr2 -/-2D2 mice associated with disease protection, including Akkermansia muciniphila, Sutterella sp., Oscillospira sp., Bacteroides acidifaciens, and Anaeroplasma sp. Conversely, Bacteroides sp., Bacteroides uniformis, and Parabacteroides sp. were abundantly present in fecal samples from female Tnfr2 -/-2D2 mice. Though it is not clear whether the increase in these bacteria was a cause or result of disease in the female Tnfr2 -/-2D2 mice, this study suggests that anti-TNF therapy may disrupt commensal-host immune homeostasis in a gender-specific manner that leads to autoimmune demyelination.
The influence of age on microbiota and immune disorders
Age-dependent disease in mouse models Airway exposure to bacteria can suppress allergic airway inflammation in adult mice. 13 However, studies indicate that such treatments could be greatly optimized by administering the therapy at an optimal age window because age is an important factor in immunoregulation of the lung. For example, an earlier report showed that exposure to endotoxin during the first 10 days of life, but not during adulthood, can cause the formation of tertiary lymphoid tissues in the lung. 14 Later, it was shown that colonization by airway microbiota early in life induces T regulatory (T reg ) cells, a T cell type that plays a major role in maintaining immune tolerance and homeostasis, which contribute to reduced susceptibility to airway hyperresponsiveness in adulthood (Fig. 1) . 15 This effect is associated with an increase in the lung bacterial load and a shift in bacterial phyla from a predominance of Gammaproteobacteria and Firmicutes to Bacteroidetes after the first 2 weeks of life. The increased accumulation of T reg cells requires the interaction of programmed death 1 (PD1) on T cells and programmed death-ligand 1 (PD-L1) on dendritic cells (DCs). Thus, the maturation of the lung microbiota during this 2-week window is a key factor for the host to develop protection against airway hyperresponsiveness.
Aside from the direct effects of lung microbiota on lung disease, recently strong interest has emerged to characterize the role of gut microbiota in lung disease. There exists a clear gut-lung axis of communication, exemplified in part by gut microbiota influences on immune disorders such as asthma, lung diseases such as chronic obstructive pulmonary disease, and respiratory infections. 16, 17 However, little is known mechanistically regarding how commensals in the gut modulate a mucosal site in the lung. Two reports point toward a tissue-specific effect of gut microbiota in regulating lung and intestinal inflammation. Invariant natural killer T (iNKT) cells recognize lipid antigens presented by CD1d. 18 Initial findings showed that, compared with specific pathogen-free (SPF) mice, germ-free (GF) mice have an increase in iNKT cells in mucosal tissues, including colon and lung. The GF mice display an enhanced inflammatory response to chemicalinduced colitis and airway hyperresponsiveness. 19, 20 Figure 1. A critical age window for microbe-mediated immunomodulation that has long-term effects on health. The lung T reg cell upsurge in early age is associated with an increase in the lung bacterial load and a shift in bacterial phyla from a predominance of Gammaproteobacteria and Firmicutes to Bacteroidetes after the first 2 weeks of life. Another pioneer study showed that in GF mice iNKT cells accumulate in both colonic lamina propria and lung, resulting in increased disease in models of IBD and asthma compared with SPF mice. The increase of iNKT cells was associated with increased intestinal and pulmonary expression of the chemokine ligand CXCL16. Importantly, colonization of neonatal, but not adult, GF mice with normal microbiota protected the animals from mucosal iNKT accumulation disease development. An et al. 19 further provided a mechanism whereby microbiota inhibit iNKT cell accumulation during the neonatal period. They found that the intestinal commensal B. fragilis reduces iNKT cells by producing sphingolipids, which inhibit iNKT cell proliferation during neonatal development. This effect lasts until adulthood, and early exposure to these lipids protects the host from later iNKT cell-mediated colitis. Finally, early-life perturbations of microbiota also lead to long-lasting effects on immunomodulation in skin. Scharschmidt et al. 21 demonstrated that skin colonization of S. epidermidis during the neonatal period was required for establishing immune tolerance to commensal microbes. This crucial window was characterized by an influx of T reg cells into neonatal skin. Together, these studies suggest that the microbial community in neonatal life is crucial in shaping immune responses to commensals, and disrupting these interactions might have lifelong consequences.
The augmented inflammation in response to chemical assaults in the intestine can be dampened in GF mice by colonization with a type of gut commensal, Bacteroides fragilis, or oral gavage with B. fragilis-derived sphingolipid during the first 2 weeks of life, but not afterward (Fig. 1) . Conversely, iNKT cell accumulation in the lung and susceptibility to airway hyperresponsiveness can be halted in GF mice by colonization with a complex microbiota community-but not by monocolonization with B. fragilis-during the first 2 weeks of life. It is particularly interesting that B. fragilis monocolonization only protects against intestinal (not lung) inflammation. This tissue specificity may be due to the local immunoregulatory effect of B. fragilis and/or B. fragilis-derived sphingolipid.
Skin also exhibits a similar age-and microbiotadependent T reg regulation. Thus, Staphylococcus epidermidis colonization on neonatal (postnatal day 7), but not adult, skin leads to immune tolerance characterized by an increase in commensal-specific T reg cells in skin and skin-draining lymph nodes, which is accompanied by reduced commensal-specific CD4 + T effector cells and diminished tissue inflammation (Fig. 1) . 21 An age-dependent effect is also present in another skin disease: psoriasis. General antibiotic treatment of adult mice reduces the severity of psoriasis, with a decrease in IL-17-and IL-22-producing T cells. However, antibiotic treatment in neonatal mice induces long-term dysregulation of the microbial composition of the skin, an effect lasting until adulthood, which ultimately leads to increased susceptibility to psoriasis development that is accompanied by an increase in IL-22-producing ␥␦ + T cells (Fig. 1) . 22 In summary, age-dependent interactions of the host and microbiota in lung, intestine, and skin can cause beneficial and/or detrimental effects on the host. This knowledge presents a unique window of opportunity for future microbial-based therapies for immune disorder-related diseases.
Human diseases: early-life perturbations of microbiota lead to lifelong consequences
In humans, there is much evidence suggesting that a change in microbiota composition in early life may affect later susceptibility to disease as an adult. For example, children exposed to farm environments have a decreased risk for the development of allergic disease. 23 In an animal model of house dust mite-induced allergies, low-dose endotoxin or farm dust protected mice from developing allergies by suppressing the activation of epithelial cells and DCs through induction of the ubiquitin-modifying enzyme A20 (encoded by Tnfaip3). 24 Combined with recent GWAS data that identified several single nucleotide polymorphisms (SNPs) in the TNFAIP3-interacting protein (TNIP-1) as being associated with asthma, the authors further discovered that TNFAIP3 SNPs are linked to asthma in children growing up on farms. Most recently, an elegant study took advantage of two similar yet distinct U.S. agricultural populations, the Amish and the Hutterites, to elucidate the role of a farm environment in asthma risk. 25 Despite their similar genetic ancestries and lifestyle, one major difference between the two groups is that the Amish use traditional farming practices, whereas the Hutterites use industrialized farming practices. Children of Hutterites develop asthma 4-6 times more often than Amish children. In addition, the dust from Amish but not Hutterite homes protected mice from developing airway hyperreactivity and eosinophilia in a murine model of asthma. The authors showed mechanistically that MYD88-and TRIF-dependent innate immune pathways are required for the protection mediated by Amish dust. Finally, the critical window for asthma control in early life, demonstrated first in animal models, has now been confirmed in human infants. Comparing the gut microbiota of 319 subjects, Arrieta et al. showed that infants at risk of asthma exhibit transient gut microbial dysbiosis during the first 100 days of life. 26 Thus, children at risk of asthma display reduced bacterial genera, including Lachnospira, Veillonella, Faecalibacterium, and Rothia. Inoculation of GF mice with these four bacterial taxa ameliorated airway inflammation, demonstrating a causative effect of the bacteria on reduction of asthma development.
With such strong evidence showing that a healthy/normal gut microbiota composition in early life is critical for lowering the incidence of immune disorders, it is not surprising to find that exposure to antibiotics can harm healthy microbiota and render the host more susceptible to many diseases. For example, antibiotic use within the first 6 months of life is associated with an increased susceptibility to allergy and asthma in later childhood. 27 Studies have also shown that antibiotic exposure during the first year of life is associated with the development of childhood wheezing and eczema, as well as inflammatory bowel disease (IBD). 28, 29 In the IBD study, those receiving antibiotics were 2.9 times (95% confidence interval: 1.2-7.0) more likely to develop IBD. 29 Another means of perturbation of the normal microbiota composition occurs in children born by cesarean section. Studies have shown that these children are more susceptible to T1D, multiple sclerosis, allergy, and asthma later in life. [30] [31] [32] The mechanistic basis for how these microbial perturbations affect disease susceptibility is unclear. However, it is clear that antibiotics can either transiently or permanently alter the composition of healthy microbiota, usually via depletion of one or several taxa. 33 Understanding this mechanism could help define the pathogenesis of dysbiosis-related immune disorders and offer major diagnostic and therapeutic opportunities.
Mucosa-associated microbiota and their immunomodulatory effects
Below, we focus on studies that show how changes in a single microbial species can alter the outcome of autoimmune diseases. Most commensals reside in the gut lumen, spatially separated from the host mucosal immune system. 34, 35 In contrast, mucosa-associated commensal species, though representing a minority within the commensal community, can powerfully modulate host immunity and disease status (Table 1) . [36] [37] [38] [39] [40] [41] For example, segmented filamentous bacteria (SFB), which can breach the intestinal mucus layer and attach to intestinal epithelial cells, are potent inducers of lamina propria T helper 17 (T H 17) cells. 28, 38 Many studies focus on SFB in animal models, 36, [42] [43] [44] [45] [46] [47] because these provide an efficient way to study the immune modulatory effect that may be induced by similar commensals in humans. Using the T H 17-inducing phenotype of SFB as a search criterion, one study discovered 20 SFB-like human commensal strains together displaying strong T H 17 induction capabilities and epithelial-adhesive features. 48 Notably, Mathis's and Benoist's group have identified a single species of human commensal, Bifidobacterium adolescentis, which was sufficient to induce T H 17 cells. 49 50 Another commensal species, B. fragilis, which resides in the mucosal crypt, was shown to induce a T H 1 response as well as regulate the crucial balance between the T H 17 and T reg response. 39 Lactobacilli, which makes up a high proportion of mucosal-associated bacteria (up to 13%), was shown to prevent IgE-mediated allergy. 40 Finally, two large-scale human studies have shown that there is an inverse association between Helicobacter pylori, a gastric mucosa pathobiont, and asthma and allergy. 51 Some reports associate the protective effect of H. pylori with its ability to induce T reg cells. 52, 53 However, the mechanisms by which H. pylori colonization in the gastric mucosa reduces asthma risk remain to be determined. 
Mechanisms by which commensals promote autoimmunity
A long-standing question in the field of hostmicrobe interaction is: how are microbes involved in the development of autoimmunity? Here, we discuss a few reported cellular and molecular mechanisms that contribute to gut microbiotadependent autoimmunity. Although autoimmune diseases occur when the adaptive immune system fails to maintain self-tolerance, the innate immune system may be a culprit in facilitating the breakdown of self-tolerance. We will discuss how innate immunity is involved in microbiotadependent autoimmunity, followed by the involvement of adaptive immunity, specifically molecular mimicry-mediated autoimmune diseases. Finally, while microbial recognition by the innate and adaptive immune system has been firmly established, recent studies have uncovered a crucial role for microbial metabolites in the orchestration of the host immune response. 54 We highlight examples of how microbiota-mediated metabolites and epigenetic modifications control the immune system and ultimately affect autoimmune development.
The innate immune system and the adjuvant effect Infection has long been linked to the onset of autoimmune disease. 2, 55 Neutrophils are a key innate immune cell type at the front line of fighting infectious diseases. 56 Neutrophils are increasingly being recognized as integral players in the cross talk between microbiota and the host immune system, as they respond to signals from the microbiota and control the expansion of the microbiome. Oral microbiota affect neutrophil phenotype, as shown by the results of a report studying Aggregatibacter actinomycetemcomitans infection. 57 This oral pathogen releases a poreforming toxin-leukotoxin A (LtxA)-which activates peptidylarginine deiminase enzymes in neutrophils and leads to hypercitrullination of self-proteins. Hypercitrullination is associated with rheumatoid arthritis (RA) development, and citrullination patterns induced by LtxA largely recapitulate those seen in RA, a finding further supported by the high concordance of anti-LtxA antibodies with RA development in human patients. These findings suggested a potential role for A. actinomycetemcomitans infection in triggering RA.
Another study compared the microbiome of three groups of infants in Northern Europe. 58 Early-onset autoimmune diseases are common in Finland and Estonia but are less prevalent in Russia. This study showed that Finnish and Estonian infants both have a greater proportion of Bacteroides species than Russia infants. 58 Therefore, the Finnish and Estonian infants are exposed to lipopolysaccharide (LPS) primarily derived from Bacteroides, which is structurally and functionally distinct from the LPS of E. coli. Unlike E. coli LPS, which is a potent innate immune activator, Bacteroides LPS inhibits innate immune signaling and endotoxin tolerance. The study further showed that, unlike LPS from E. coli, LPS from Bacteroides dorei, a species of Bacteroides, does not decrease the incidence of autoimmune diabetes in NOD mice. Interestingly, B. dorei has been shown to be associated with T1D pathogenesis. 59 Early colonization with immunologically silencing microbiota may thus preclude some aspects of immune education.
LPS is the ligand for Toll-like receptor 4 (TLR4), and another study along similar lines revealed the contribution of TLR4 in ameliorating autoimmune diabetes in NOD mice. 60 TRIF is a downstream signaling molecule of TLR4 and TLR3. TRIF gene deletion causes an increased incidence of autoimmune diabetes in NOD mice, suggesting a protective role for TRIF against autoimmune diabetes.
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Mice with a gene knockout of TLR4 but not TLR3 in an SPF facility have accelerated autoimmune diabetes, 61, 62 and TLR4 gene knockout mice in a GF facility have normal T1D incidence, suggesting that microbiota-dependent TLR4/TRIF signaling protects against T1D. Conversely, TLR2 gene deletion reduces the incidence of autoimmune diabetes, which is reversed when TLR2 gene knockout NOD mice are re-derived into the GF environment. 60 These findings suggest that microbiota deliver a prodiabetic signal through TLR2. Together, these results suggest that differences in microbiota-derived LPS among individuals may prevent their immune tolerance education, leading to autoimmune disease. These studies also indicate that microbiota can promote or inhibit autoimmunity by signaling through different receptors.
The IL-2 signaling pathway potently inhibits T follicular helper (T FH ) cell differentiation by decreasing Bcl-6 expression. 63, 64 We discovered that SFB drive the T FH response via a DC-dependent adjuvant effect that is independent of TCR specificity. 47 Using a DC transfer model, we found that SFB-mediated Bcl-6 upregulation corresponds with SFB-mediated, DC-dependent IL-2R␣ + CD4
+ suppression that occurs only in Peyer's patches (PPs). Consistent with other findings suggesting that IL-2 functions as a potent inhibitor of T FH differentiation, anti-IL-2 treatment boosts the T FH response, which leads to arthritis enhancement in SFB -K/BxN mice, and SFB colonization does not further enhance these effects in the anti-IL-2-treated mice. These data suggest that the mechanism of SFB-triggered T FH cell differentiation overlaps with anti-IL-2 treatment, which depends on suppression of the IL-2 signaling pathway. Our findings indicate that T cells can differentiate into T FH cells upon receiving an SFB-mediated, DC-derived bystander signal that restrains IL-2 signaling, regardless of TCR Ag-specificity. Although molecular mimicry is a prominent mechanism whereby microbial infections trigger autoimmunity (see below), it is very unlikely that SFB induce differentiation of autoimmune T cells into T FH cells by molecular mimicry of the self-antigen glucose-6-phosphate isomerase in the K/BxN model, because our data show that SFB also induce T FH differentiation in the NZB/NZW F1 mice, a nontransgenic murine SLE model. 47 Our finding that SFB mediate bystander activation of GPI-specific T FH cells is supported by a recent report showing that SFB induced vigorous GC formation but a very low percentage of SFB-specific IgA in PPs compared with a commensal strain of E. coli. 44 Previous reports demonstrated an autoimmune-enhancing effect of SFB via the induction of T H 17 cells. 42, 65 Chappert et al. showed that in a T H 1 cell-driven murine model of autoimmune arthritis, SFB modulate the activation threshold of self-reactive T cells and enhance autoimmune arthritis. 66 Interestingly, they found that SFB enhance disease by inducing T H 1 but not T H 17 cells. In the local microenvironment of gut-associated lymphoid tissues, inflammatory cytokines-particularly IL-12 elicited by the commensal flora-preferentially enhanced the T cell response to self-antigen that was otherwise tuned down.
Molecular mimicry
Molecular mimicry is a well-known mechanism for bacterial or viral infection-triggered autoimmunity. 1, 67 However, whether gut commensal bacteria can also trigger autoimmunity by molecular mimicry is poorly understood. Two studies have recently shed light on this topic (Fig. 2) . The first report studied autoimmune uveitis, a major cause of blindness. Autoreactive retina-specific T cells were hypothesized to first become activated at noneye sites and induce autoimmune uveitis by breaking through the blood-retinal barrier, given that their cognate antigens are sequestered within the immune-privileged eye. 68 To test this hypothesis, Horai et al. used a TCR transgenic mouse model that recognizes interphotoreceptor retinoid-binding protein (IRBP), a self-antigen, and demonstrated that gut commensals are required for the development of autoimmune uveitis. Retinaspecific T cells are activated in a host that does not express self-antigen IRBP, and their activation is also independent of bacterial superantigens. Signaling through the retina-specific TCR by a protein extract derived from commensals is critical for the activation of retina-specific T cells, which can be blocked by anti-MHC class II antibodies, suggesting that the activation signals require TCR-MHC interactions. Although a molecular mimicry epitope was not identified in this study, it is conceivable that retina-specific TCRs can be activated by crossreactive products derived from commensals independent of the IRBP self-antigen.
The second study used islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP)-specific CD8 TCR transgenic NOD mice to demonstrate that the gut microbiota strongly modulate CD8
+ T cell-mediated T1D development (Fig. 2) . 69 The authors further discovered that one type of commensal, fusobacteria, expresses peptides that share significant homology with IGRP and promote diabetes development. Thus, molecular mimicry between commensal antigens and an islet self-antigen provokes autoimmune diabetes. These studies raise a critical warning that activation of auto-reactive TCRs by commensal bacteria might be a more frequent trigger of autoimmune diseases than is currently appreciated.
Metabolites: short-chain fatty acids
Short-chain fatty acids (SCFAs), including butyric acid, propionic acid, and acetic acid, are the main metabolic products of undigested carbohydrates and have broad effects on the host immune system. Recently, one group reported that long-chain fatty acids (LCFAs) enhanced the differentiation and proliferation of T H 1 and/or T H 17 cells, while SCFAs expanded gut T reg cells. 71 Using experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis, Haghikia et al. showed that LCFAs decreased SCFAs in the gut, leading to exacerbated EAE by expanding pathogenic T H 1 and/or T H 17 cells in the small intestine. Treatment with SCFAs ameliorated EAE by inducing lamina propria-derived T reg cells. SCFAs can also indirectly regulate autoimmunity through other molecules, such as antimicrobial peptides (AMPs), expressed by epithelial and immune cells for their defense function against invading microbes.
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Interestingly, ␤ cells have been shown to produce the cathelicidin-related antimicrobial peptide (CRAMP), and this production was defective in female but not in male NOD mice. 73 Systemic CRAMP administration to female NOD mice induced T reg cells in the pancreatic islets and reduced the incidence of autoimmune diabetes. Mechanistically, the production of CRAMP by ␤ cells was controlled by SCFAs produced by the gut microbiota. Fecal transplant of gut microbiota from male NOD mice to female NOD recipients increases CRAMP production and reduces the incidence of diabetes, indicating a causative effect of male gut microbiota in controlling autoimmune diabetes.
Metabolites: retinoic acid
Retinoic acid, a metabolite of vitamin A, has a wide range of biological activity, including regulating immune responses. 74 A major part of retinoic acid's anti-inflammatory effects depends on the inhibition of T H 17 and promotion of FOXP3 + T reg responses. 74, 75 AM80 is a synthetic retinoic acid that is characterized by higher stability and fewer potential adverse effects compared with all-transretinoic acid, one of the most active physiological retinoid metabolites. 76, 77 It has been reported that retinoic acid and AM80 ameliorate many autoimmune responses, including experimental autoimmune myositis, experimental autoimmune encephalitis, and collagen-induced arthritis. [78] [79] [80] [81] We recently showed that oral administration of AM80 inhibits autoimmune disease in joints as well as in lung. 82 We elucidated a novel mechanism whereby AM80 suppresses the autoimmune pathology at both lung and joints by inhibiting T FH and T H 17 responses. Specifically, AM80 increased the expression of the gut-homing integrin ␣ 4 ␤ 7 on T FH cells, which diverted T FH cells from systemic (nongut) inflamed sites, such as lung, into the gut (the nonimmunopathological site) and thus reduced the systemic auto-Abs.
Metabolites: uric acid
It is worth mentioning that although most studies have focused on the bacterial microbiota, the gut microbial communities also include fungi and viruses. One study has reported that Saccharomyces cerevisiae exacerbated intestinal disease in a mouse model of colitis and increased gut barrier permeability by enhancing host purine metabolism, leading to an increase in uric acid production. 83 Thus, fungi in the gut may be able to potentiate metabolite production that worsens the development of IBD.
Microbiota-mediated epigenetic modifications
One of the mechanisms by which the microbiota affect the host is by triggering epigenetic changes in host cells. This often occurs through histone acetylation controlled by microbial metabolites, such as SCFAs. [84] [85] [86] Administration of propionate rescued the T reg population in GF mice, restoring percentage and numbers comparable to those in SPF mice, as well as increasing T reg expression of FOXP3, TGF-␤, and IL-10 in vitro. These effects were mediated by inhibition of histone deacetylases (HDACs) 9 and 6, which led to increased histone acetylation. 86 Similarly, butyrate was found by multiple groups to increase histone acetylation in order to promote peripheral or colonic T reg differentiation. 84, 85 Naive CD4 + T cells cultured under T reg -inducing conditions in the presence of butyrate exhibited increased histone acetylation at the promoter and conserved noncoding sequence 3 (CNS3) of FOXP3 compared with those cultured without butyrate, and Rag1 -/-mice fed butyrate were protected against T cellinduced colitis in a T reg -dependent manner. 85 In another study, Arpaia et al. found that butyrate inhibited HDACs in order to increase histone acetylation in DCs, enhancing their ability to promote T reg differentiation. This effect was dependent on peripheral T reg differentiation, as mice lacking CNS1-an intronic enhancer required for extrathymic but not thymic T reg differentiationin FOXP3-expressing cells failed to respond to butyrate. 84 These studies demonstrate that the commensal microbiota mediate protection against autoimmunity in part through histone modifications that promote T reg proliferation and differentiation. It is interesting to note that these modifications occur in multiple cell populations, including T reg cells themselves as well as DCs, demonstrating the wide target range of microbiota by-products. 84 The microbiota cause other epigenetic modifications, such as alterations in DNA or histone methylation. The previously mentioned iNKT-enhanced inflammatory response to chemical-induced colitis and airway hyperresponsiveness in GF mice were due to increased DNA methylation at five CpG sites in the gene for CXCL16, which results in a significant increase in iNKT cell numbers. 20 Another group found that NK cells were actually less reactive to stimuli than their counterparts from SPF mice. 87 Furthermore, TLR ligand-induced type I IFN production, as well as IL-6, TNF-␣, IL-12, and IL-18, was systemically impaired in DCs of GF mice or mice treated with broad-spectrum antibiotics, which was connected to the absence of trimethylation on histone H3, lysine 4 (H3K4) in the regulatory regions of these cytokine genes in DCs, presumably impairing their ability to prime NK cells. Thus, the microbiota epigenetically regulate gene expression to dampen autoimmune inflammation but increase the ability to respond to outside challenges.
Linking gut microbiota to gut-distal autoimmune diseases
It is clear that dysbiosis of gut microbiota affects many extraintestinal autoimmune diseases and immune disorders, including RA, T1D, multiple sclerosis, and asthma. 7, 88 How do microbiota residing in the gut affect disease outside the gut? To address this question, we took advantage of the KikGR transgenic mouse line, which ubiquitously expresses the green-to-red photoconvertible fluorescent protein in its cells. 89, 90 We first generated KikGR.K/BxN mice, which express the KikGR transgene on the K/BxN background. We then developed a surgical procedure to specifically photoconvert and hence mark PP cells by treating PPs with violet laser light and subsequently monitored the migration of these photoconverted PP cells to the spleen. 47 It has been reported that 3 days is the best time point to detect an arrival of photoconverted, colon-derived T conventional cells into the spleen, using Kaede mice, a transgenic photoconversion mouse model similar to the KikGR mouse model. 91 Thus, we monitored the converted PP cell migration into the spleen 3 days after surgery. A significant number of photoconverted, migratory CD4 + T cells from PPs were detected in the spleens of the KikGR.K/BxN mice after PP violet light exposure compared with controls with sham surgery, regardless of their SFB status (Fig. 3) . Interestingly, there is a cell type-specific contribution to the photoconverted CD4 + T cell pool in the spleen: a significantly higher portion of the newly arrived and PP-derived photoconverted CD4 + T cells in the spleen were T FH cells, compared with the SFB -group. Thus, these results provide direct evidence that SFB colonization preferentially boosts T FH cell migration from PPs to the spleen and suggest a potential role for microbiota-driven and gut-derived immune cells in modulating systemic autoimmunity by entering systemic sites. A later report provides further evidence for gut microbiota-dependent cell migration from the gut to another extraintestinal site, the kidney, contributing to autoimmune development (Fig. 3) . 92 T H 17 cells are most abundant in the gut during homeostasis, and some reports have suggested that they are produced in a microbiota-dependent manner. 36 Krebs et al. found a high percentage of T H 17 cells in the kidneys of patients with antineutrophil cytoplasmatic antibody-associated glomerulonephritis. They utilized Kaede mice to track intestinal T cell migration upon glomerulonephritis induction, and found that T H 17 cells egress from the intestine in an S1P receptor-1-dependent fashion. These T H 17 cells subsequently migrate to the kidney via the T H 17 chemoattractant CCL20 through interaction with CCR6 expressed by the T H 17 cells. Depletion of gut T H 17 cells in GF and vancomycin-treated mice ameliorated the autoimmune glomerulonephritis. Thus, targeting the intestinal T H 17 cell reservoir may offer a therapeutic strategy for autoimmune diseases.
Conclusions and future directions
There is a surge of recent studies reporting the associations of host disease with dysbiosis, including reduction of microbial diversity and/or aberrant microbial communities. 93, 94 Although these studies provide promising clinical implications, various challenges need to be overcome by the field in order to harness these findings for future diagnostic and therapeutic approaches. One huge challenge lying ahead is to distinguish cause from effect (i.e., whether the gut microbiota are the cause of the disease or a result of the disease state). The use of animal models where the intestinal flora can be manipulated provides a powerful tool for such mechanistic studies. Second, despite the focus on taxonomic composition analyzed by 16S rRNA sequencing of microbial communities in many studies, the functional relevance of microbial communities is more likely to be revealed by their metagenomic gene expression and metabolomics profiles. This is further demonstrated by the fact that bacterial isolates of the same strain can display very different immunoregulatory capabilities. 50 Finally, the therapeutic effect of probiotics on dysbiosis-related disease may rely on a very specific composition of microbiota, with a few exceptions, such as in Clostridium difficile infection, as the antibiotic-induced dysbiosis that triggers C. difficile infection is so extreme that most fecal transplantations prove to be beneficial. 95 A stable engraftment of a defined commensal community can be challenging. A better understanding of host-microbe interaction and the underlying microbiota-derived molecules that modulate the immune system and disease development may help pave the way for better patient-tailored interventions and microbial molecule(s)-based therapies for immune disorders.
